DC Female Condom program highly effective in preventing HIV infections

A new economic analysis, conducted by Johns Hopkins Bloomberg School of Public Health and featured in the current issue of Springer's journal AIDS and Behavior, showed that the DC Female Condom program, a public-private partnership to provide and promote female condoms, prevented enough HIV infections in the first year alone to save over $8 million in future medical care costs (over and above the cost of the program). This means that for every dollar spent on the program, there was a cost savings of nearly $20.

This coalition led by the DC Department of Health (DOH) with support from the Washington AIDS Partnership, CVS/Caremark and the Female Health Company provided educational services and distributed more than 200,000 female condoms in areas in the District with disproportionately high rates among women. The MAC AIDS Fund provided funding support for the project, which subsequently engaged five community-based organizations already working in the field of women's health and HIV/STD prevention to assist with education and distribution activities.

"These results clearly indicate that delivery of, and education about, female condoms is an effective HIV prevention intervention and an outstanding public health investment. Similar community HIV prevention programs involving the should be explored for replication in other high risk areas," said Dr. David R. Holtgrave, professor and chair of the Department of Health Behavior and Society at the Johns Hopkins Bloomberg School of Public Health and a national expert in evaluating the efficacy and cost-effectiveness of HIV prevention interventions.

Women, particularly in urban areas like the District, are disproportionately affected by HIV/AIDS. Black women account for roughly 57 percent of new HIV infections in all American women and 90 percent of all new HIV infections in the District. The success and affordability of this pilot program suggests that promotion and education of the female condom can have significant impact to improve the health of women who are at risk of contracting HIV.

"We are extremely excited and encouraged by the success of the DC female condom program. The District still has a serious HIV epidemic and women are at risk. It is critical that we empower women, especially those at greatest risk, to take control by increasing awareness of the female condom and providing both education and access to this highly effective and affordable option that empowers women to protect themselves," said Dr. Gregory Pappas, Senior Deputy Director HIV/AIDS STD Administration, DC Department of .

More information: Holtgrave DR et al. (2012). Cost-Utility Analysis of a Female Condom Promotion Program in Washington, DC. AIDS and Behavior; DOI 10.1007/s10461-012-0174-5

Related Stories

Yes, a female condom

date Jan 28, 2009

Sometime during the next six months, the U.S. Food and Drug Administration will consider approving the FC2, a second-generation female condom. That appears likely, since an FDA advisory panel unanimously recommended the product ...

DC pushes female condoms to fight HIV epidemic

date Jul 28, 2010

(AP) -- Charlene Cotton will talk to anyone about sex. Several days a week she stands behind a table decorated with a bowl of flavored condoms and safer sex pamphlets, calling to women passing on the street, ...

Recommended for you

HIV reservoirs remain obstacles to cure

date May 19, 2015

Antiretroviral therapy (ART) has proven lifesaving for people infected with HIV; however, the medications are a lifelong necessity for most HIV-infected individuals and present practical, logistical, economic ...

Microclinics help keep Kenyan HIV patients in care

date May 18, 2015

A team led by researchers from UC San Francisco, Organic Health Response, and Microclinic International is reporting results of a study that showed significant benefits of microclinics—an innovative intervention ...

'Redesigned' antibodies may control HIV

date May 18, 2015

With the help of a computer program called "Rosetta," researchers at Vanderbilt University have "redesigned" an antibody that has increased potency and can neutralize more strains of the AIDS-causing human ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.